Max Robotics — Global Service Robot Directory + US Certification

About

Ryo Takata is a pioneering urologic surgeon whose research centers on optimizing outcomes in robot-assisted surgery for prostate and kidney cancers. His most influential work, with 29 citations, established that preoperative membranous urethral length is a critical predictor of urinary continence recovery after robot-assisted laparoscopic prostatectomy—a finding that directly informs surgical planning and patient counseling. Takata has also identified predictive factors for biochemical recurrence in high-risk prostate cancer patients (18 citations), helping refine risk stratification. Demonstrating innovation in surgical education, his 2021 study showed that repeated virtual reality simulator training can reduce three-dimensional motion sickness among medical students, addressing a key barrier to robotic surgery training. His contributions extend to renal surgery, where he used 99m-Tc DTPA renal scintigraphy to assess long-term split renal function after robot-assisted partial nephrectomy, and he has reported complex concurrent procedures for synchronous prostate and kidney tumors. Takata’s work on reconstructing the Retzius space to improve postoperative incontinence further underscores his commitment to enhancing patient quality of life. With a growing portfolio addressing both technical outcomes and educational challenges, he is advancing the precision and accessibility of robotic urologic surgery.